Pfizer advances with its projects to contribute to the treatment and prevention of Covid-19

News about our members

April 13th 2020Members news

The president and CEO of Pfizer, Albert Bourla, has highlighted the advances of the American company in the 5-Point Plan that have been proposed to contribute, together with other partners in the industry and academic institutions, to develop novel approaches to prevent and treat COVID-19.

READ MORE

recently published

Post thumb
Informative breakfasts "Study on the market of biosimilar medicines in the National Health System in Spain"
March 18 2024
Post thumb
Horizon scanning
Jan 31 2024
Post thumb
Early Treatment: the role of biosimilars
18 2023 December
Post thumb
Study on the market for biosimilar medicines in the National Health System in Spain 2016-2022
18 2023 December

BioSim Newsletter

Subscribe to receive a weekly summary of current events on biosimilar medicines in your email.

SUBSCRIBE